Curi RMB Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Curi RMB Capital’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-39,625	Closed	-$284K	–	705
2019 Q2	$284K	Sell	39,625 -3,952	-9%	-$40.4K	0.01%	642
2019 Q1	$617K	Sell	43,577 -18,182	-29%	-$240K	0.02%	533
2018 Q4	$836K	Buy	61,759 +13,988	+29%	+$252K	0.02%	534
2018 Q3	$1.06M	Hold	47,771	–	–	0.03%	492
2018 Q2	$784K	Buy	+47,771	New	+$838K	0.02%	549

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Curi RMB Capital's AMRX Position: Q3 2019 in Review

Curi RMB Capital sold out of Amneal Pharmaceuticals (AMRX) in Q3 2019, closing a stake of 39,625 shares — an estimated $284K sold.

Curi RMB Capital first reported a position in AMRX in Q2 2018 and held it in 5 quarters. The position peaked at $1.06M in Q3 2018. 121 funds tracked by Wall St. Rank hold AMRX as of Q3 2019.

Curi RMB Capital reported no remaining Amneal Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Curi RMB Capital sold 39,625 Amneal Pharmaceuticals shares in Q3 2019, an estimated $284K.
Curi RMB Capital first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 5 quarters.
Curi RMB Capital's Amneal Pharmaceuticals position peaked at $1.06M in Q3 2018.
121 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2019.

Based on Curi RMB Capital's 13F filing for Q3 2019, filed 12 Nov 2019.